Related Experiment Video

Updated: Jul 16, 2026

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

12.0K

MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy

Terry J Prins1, Thomas J Lai2, Tie Li1

  • 1Department of Neurology, University of California, Los Angeles, 10833 Le Conte Ave, BOX 957066, CHS 36-128, Los Angeles, CA, 90095-7066, USA.

Journal of Neuro-Oncology
|March 12, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
MGMT-methylationCRISPRGliomaRNA-guided RNA targetingTemozolomide

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.0K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K

Related Experiment Videos

Last Updated: Jul 16, 2026

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

12.0K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.0K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

High-throughput spheroid profiling reveals BMP-driven rewiring of glioma cell death responses.

bioRxiv : the preprint server for biology·2026

Imaging patterns of necrosis after treatment with chemoradiation are prognostic for survival in glioblastoma.

European radiology·2026

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab.

Journal of neuro-oncology·2026

Characterizing Parental Use of a HIPAA-Compliant Large Language Model Chatbot in Rare Pediatric Diseases: Insights from Think-Aloud Sessions.

Applied clinical informatics·2026

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Glutamatergic neuron-tumor synapses shape human glioblastoma cell states through radial glia plasticity.

bioRxiv : the preprint server for biology·2026

Dose selection and clinical decision-making after Gamma Knife surgery for large brain metastases: implications for early identification of true progression.

Journal of neuro-oncology·2026

Predictive modeling of lung cancer subtype with integration of clinical and thoracic imaging features to guide early brain metastasis management.

Journal of neuro-oncology·2026

Surgical characteristics and postoperative outcomes in a retrospective cohort study of patients with molecularly defined oligodendroglioma.

Journal of neuro-oncology·2026

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice.

Journal of neuro-oncology·2026

[18F]FET uptake in diffuse lower-grade IDH-mutant glioma correlates with glioma-related epilepsy.

Journal of neuro-oncology·2026

A patient-derived organoid platform for predominantly posterior fossa adult ependymoma: histopathologic preservation, culture-associated transcriptomic remodeling, and in vivo tumorigenicity.

Journal of neuro-oncology·2026

A murine model of amyloid enhanced tauopathy: progressive changes in tau pathology and behavior.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Integrating deep learning model for precision design of MERS antibodies with augmented affinity against SARS-CoV-2.

Journal of biomolecular structure & dynamics·2026

Impact of the physico-chemical properties of surface-initiated polymer brushes on siRNA binding and transfection efficiency.

Biomaterials science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us